🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. Vedolizumab IV

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  2. Velaglucerase Alfa

    Takeda

    Gaucher Disease

    approved small molecule completed

    4 trials

  3. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial

  4. Vyndaqel 61 mg soft capsules

    Monte Rosa Therapeutics

    Transthyretin cardiac amyloidosis

    approved small molecule active

    1 trial

  5. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  6. Vyvgart 20 mg/mL concentrate for solution for infusion

    The George Institute

    Patients affected by generalized myasthenia gravis

    approved small molecule active

    1 trial

  7. Xolair

    United Therapeutics Europe Ltd

    Atopic Eczema

    approved small molecule completed

    1 trial

  8. Z-Brace interbody fusion device

    Hospital Authority, Hong Kong

    Cervical Disc Degeneration

    approved other active

    1 trial

  9. ZYNRELEF 200Mg-6Mg Extended-Release Solution

    Heron Therapeutics

    Post Operative Pain, Acute

    approved small molecule active

    1 trial

  10. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  11. Zithromax

    United Therapeutics Europe Ltd

    Asthma

    approved small molecule completed

    1 trial

  12. Zoledronate

    United Therapeutics Europe Ltd

    Hip Fractures

    approved small molecule active

    1 trial

  13. aflibercept 2.0 mg

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule completed

    1 trial

  14. allopurinol

    United Therapeutics Europe Ltd

    Gout

    approved small molecule completed

    1 trial

  15. artemether lumefantrine

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  16. artemether-lumefantrine (ALN)

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  17. aspirin 100mg/d therapy

    The First People's Hospital of Lianyungang

    Coronary Atherosclerosis

    approved small molecule active

    1 trial

  18. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

  19. buprenorphine/naloxone

    BICYCLE THERAPEUTICS

    Opioid Use Disorder

    approved small molecule terminated

    1 trial

  20. combined fixed dose combination

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    1 trial

  21. combined fixed dose combination

    Gain Therapeutics

    Tuberculosis

    approved small molecule active

    1 trial

  22. dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  23. dipyridamole

    United Therapeutics Europe Ltd

    Coronary Artery Disease

    approved small molecule terminated

    1 trial

  24. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources